Approach to the prevention of atypical hemolytic uremic syndrome recurrence using eculizumab in a pregnant kidney transplant recipient with complement factor H gene mutation: a case report and literature review

Cheung CK, Nettleton KJ, Williams ML, Page AS, Littler Y, Goodlife A, Singhal T, Brunskill NJ, Carr SJ (2019) Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS. Kidney Int Rep 4:1658. https://doi.org/10.1016/j.ekir.2019.08.020

Article  PubMed  PubMed Central  Google Scholar 

Duval A, Olagne J, Cognard N, Gautier Vargas G, Joly M, Perrin P, Fritz G, Fourtage M, Moulin B, Caillard S (2019) Pregnancy in a kidney transplant woman under treatment with eculizumab for atypical hemolytic uremic syndrome: is it safe? Kidney Int Rep 4:733–739. https://doi.org/10.1016/j.ekir.2018.12.014

Article  PubMed  PubMed Central  Google Scholar 

Fakhouri F, Fila M, Hummel A, Ribes D, Sellier-Leclerc A-L, Ville S, Pouteil-Noble C, Coindre J-P, Le Quintrec M, Rondeau E, Boyer O, Provôt F, Djeddi D, Hanf W, Delmas Y, Louillet F, Lahoche A, Favre G, Châtelet V, Launay EA, Presne C, Zaloszyc A, Caillard S, Bally S, Raimbourg Q, Tricot L, Mousson C, Le Thuaut A, Loirat C, Frémeaux-Bacchi V (2021) Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study. Blood 137:2438–2449. https://doi.org/10.1182/blood.2020009280

Article  CAS  PubMed  Google Scholar 

Fakhouri F, Roumenina L, Provot F, Sallée M, Caillard S, Couzi L, Essig M, Ribes D, Dragon-Durey M-A, Bridoux F, Rondeau E, Frémeaux-Bacchi V (2010) Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 21:859. https://doi.org/10.1681/ASN.2009070706

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glover EK, Smith-Jackson K, Brocklebank V, Wilson V, Walsh PR, Montgomery EK, Wong EKS, Johnson S, Malina M, Kavanagh D, Sheerin NS (2023) Assessing the impact of prophylactic eculizumab on renal graft survival in atypical hemolytic uremic syndrome. Transplantation 107:994–1003. https://doi.org/10.1097/TP.0000000000004355

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke O-L, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2015) Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. Immunobiology 220:452–459. https://doi.org/10.1016/j.imbio.2014.11.003

Article  CAS  PubMed  Google Scholar 

Haninger-Vacariu N, Aigner C, Kain R, Prohászka Z, Gaggl M, Böhmig GA, Piggott LC, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A (2020) Successful pregnancies during ongoing eculizumab therapy in two patients with complement-mediated thrombotic microangiopathy. Kidney Med 2:213. https://doi.org/10.1016/j.xkme.2019.12.004

Article  PubMed  PubMed Central  Google Scholar 

Kelly RJ, Höchsmann B, Szer J, Kulasekararaj A, de Guibert S, Röth A, Weitz IC, Armstrong E, Risitano AM, Patriquin CJ, Terriou L, Muus P, Hill A, Turner MP, Schrezenmeier H, de Latour RP (2015) Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 373:1032–1039. https://doi.org/10.1056/NEJMoa1502950

Article  CAS  PubMed  Google Scholar 

Martín Merinero H, Zhang Y, Arjona E, del Angel G, Goodfellow R, Gomez-Rubio E, Ji R-R, Michelena M, Smith RJH, Rodríguez de Córdoba S (2021) Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification. Blood 138:2185–2201. https://doi.org/10.1182/blood.2021012037

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKay DB, Josephson MA (2008) Pregnancy after kidney transplantation. Clin J Am Soc Nephrol CJASN 3:S117–S125. https://doi.org/10.2215/CJN.02980707

Article  PubMed  Google Scholar 

Regal JF, Burwick RM, Fleming SD (2017) The complement system and preeclampsia. Curr Hypertens Rep 19:87. https://doi.org/10.1007/s11906-017-0784-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Servais A, Devillard N, Frémeaux-Bacchi V, Hummel A, Salomon L, Contin-Bordes C, Gomer H, Legendre C, Delmas Y (2016) Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab. Nephrol Dial Transplant 31:2122–2130. https://doi.org/10.1093/ndt/gfw314

Article  CAS  PubMed  Google Scholar 

Sikma MA, Van Maarseveen EM, Hunault CC, Moreno JM, Van de Graaf EA, Kirkels JH, Verhaar MC, Grutters JC, Kesecioglu J, De Lange DW, Huitema ADR (2020) Unbound plasma, total plasma, and whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation. Clin Pharmacokinet 59:771–780. https://doi.org/10.1007/s40262-019-00854-1

Article  CAS  PubMed  Google Scholar 

Wiles K, Bramham K, Seed PT, Brockbank A, Nelson-Piercy C, Karumanchi SA, Lightstone L, Chappell LC (2021) Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens 24:58–64. https://doi.org/10.1016/j.preghy.2021.02.010

Article  PubMed  Google Scholar 

Zheng S, Easterling TR, Umans JG, Miodovnik M, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF (2012) Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 34:660–670. https://doi.org/10.1097/FTD.0b013e3182708edf

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif